APO Research
Talk to an analyst

APO RESEARCH · REPORT

BNCT Treatment

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global BNCT Treatment Market Analysis and Forecast 2026-2032

4 March 2026198 pages

Choose your research edition.

Industry ResearchBNCT Treatment Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal BNCT Treatment Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal BNCT Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal BNCT Treatment Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal BNCT Treatment Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global BNCT Treatment market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for BNCT Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for BNCT Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for BNCT Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for BNCT Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of BNCT Treatment include Neutron Therapeutics, Sumitomo Heavy Industries, International Particle Therapy Inc (IPT), RaySearch, Neuboron Medtech, TAE Life Sciences and Stella Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for BNCT Treatment, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of BNCT Treatment, also provides the revenue of main regions and countries. Of the upcoming market potential for BNCT Treatment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the BNCT Treatment revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global BNCT Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for BNCT Treatment revenue, projected growth trends, production technology, application and end-user industry.

BNCT Treatment Segment by Company

Neutron Therapeutics

Sumitomo Heavy Industries

International Particle Therapy Inc (IPT)

RaySearch

Neuboron Medtech

TAE Life Sciences

Stella Pharma

BNCT Treatment Segment by Type

Equipment

Solution

Drug

BNCT Treatment Segment by Application

Head and Neck Cancer

Brain Tumor

Others

BNCT Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global BNCT Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of BNCT Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of BNCT Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of BNCT Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of BNCT Treatment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, BNCT Treatment revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global BNCT Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Equipment Major Player Table 3. Solution Major Player Table 4. Drug Major Player Table 5. Global BNCT Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Head and Neck Cancer Major Player Table 7. Brain Tumor Major Player Table 8. Others Major Player Table 9. BNCT Treatment Industry Trends Table 10. BNCT Treatment Industry Drivers Table 11. BNCT Treatment Industry Opportunities and Challenges Table 12. BNCT Treatment Industry Restraints Table 13. Global BNCT Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global BNCT Treatment Market Size by Region (2021-2026) & (US$ Million) Table 15. Global BNCT Treatment Market Share by Region (2021-2026) Table 16. Global BNCT Treatment Market Size by Region (2027-2032) & (US$ Million) Table 17. Global BNCT Treatment Market Share by Region (2027-2032) Table 18. Global BNCT Treatment Revenue by Players (US$ Million) & (2021-2026) Table 19. Global BNCT Treatment Revenue Market Share by Players (2021-2026) Table 20. Global BNCT Treatment Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global BNCT Treatment Key Players Headquarters & Area Served Table 22. Global BNCT Treatment Players, Product Type & Application Table 23. Global BNCT Treatment Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global BNCT Treatment by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global BNCT Treatment Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global BNCT Treatment Revenue by Type (2021-2026) & (US$ Million) Table 28. Global BNCT Treatment Revenue by Type (2027-2032) & (US$ Million) Table 29. Global BNCT Treatment Revenue Market Share by Type (2021-2026) Table 30. Global BNCT Treatment Revenue Market Share by Type (2027-2032) Table 31. Global BNCT Treatment Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global BNCT Treatment Revenue by Application (2021-2026) & (US$ Million) Table 33. Global BNCT Treatment Revenue by Application (2027-2032) & (US$ Million) Table 34. Global BNCT Treatment Revenue Market Share by Application (2021-2026) Table 35. Global BNCT Treatment Revenue Market Share by Application (2027-2032) Table 36. Neutron Therapeutics Company Information Table 37. Neutron Therapeutics Business Overview Table 38. Neutron Therapeutics BNCT Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Neutron Therapeutics BNCT Treatment Product Portfolio Table 40. Neutron Therapeutics Recent Development Table 41. Sumitomo Heavy Industries Company Information Table 42. Sumitomo Heavy Industries Business Overview Table 43. Sumitomo Heavy Industries BNCT Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Sumitomo Heavy Industries BNCT Treatment Product Portfolio Table 45. Sumitomo Heavy Industries Recent Development Table 46. International Particle Therapy Inc (IPT) Company Information Table 47. International Particle Therapy Inc (IPT) Business Overview Table 48. International Particle Therapy Inc (IPT) BNCT Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. International Particle Therapy Inc (IPT) BNCT Treatment Product Portfolio Table 50. International Particle Therapy Inc (IPT) Recent Development Table 51. RaySearch Company Information Table 52. RaySearch Business Overview Table 53. RaySearch BNCT Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. RaySearch BNCT Treatment Product Portfolio Table 55. RaySearch Recent Development Table 56. Neuboron Medtech Company Information Table 57. Neuboron Medtech Business Overview Table 58. Neuboron Medtech BNCT Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Neuboron Medtech BNCT Treatment Product Portfolio Table 60. Neuboron Medtech Recent Development Table 61. TAE Life Sciences Company Information Table 62. TAE Life Sciences Business Overview Table 63. TAE Life Sciences BNCT Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. TAE Life Sciences BNCT Treatment Product Portfolio Table 65. TAE Life Sciences Recent Development Table 66. Stella Pharma Company Information Table 67. Stella Pharma Business Overview Table 68. Stella Pharma BNCT Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Stella Pharma BNCT Treatment Product Portfolio Table 70. Stella Pharma Recent Development Table 71. North America BNCT Treatment Revenue by Type (2021-2026) & (US$ Million) Table 72. North America BNCT Treatment Revenue by Type (2027-2032) & (US$ Million) Table 73. North America BNCT Treatment Revenue by Application (2021-2026) & (US$ Million) Table 74. North America BNCT Treatment Revenue by Application (2027-2032) & (US$ Million) Table 75. North America BNCT Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 76. North America BNCT Treatment Revenue by Country (2021-2026) & (US$ Million) Table 77. North America BNCT Treatment Revenue by Country (US$ Million) & (2027-2032) Table 78. Europe BNCT Treatment Revenue by Type (2021-2026) & (US$ Million) Table 79. Europe BNCT Treatment Revenue by Type (2027-2032) & (US$ Million) Table 80. Europe BNCT Treatment Revenue by Application (2021-2026) & (US$ Million) Table 81. Europe BNCT Treatment Revenue by Application (2027-2032) & (US$ Million) Table 82. Europe BNCT Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 83. Europe BNCT Treatment Revenue by Country (2021-2026) & (US$ Million) Table 84. Europe BNCT Treatment Revenue by Country (US$ Million) & (2027-2032) Table 85. China BNCT Treatment Revenue by Type (2021-2026) & (US$ Million) Table 86. China BNCT Treatment Revenue by Type (2027-2032) & (US$ Million) Table 87. China BNCT Treatment Revenue by Application (2021-2026) & (US$ Million) Table 88. China BNCT Treatment Revenue by Application (2027-2032) & (US$ Million) Table 89. Asia BNCT Treatment Revenue by Type (2021-2026) & (US$ Million) Table 90. Asia BNCT Treatment Revenue by Type (2027-2032) & (US$ Million) Table 91. Asia BNCT Treatment Revenue by Application (2021-2026) & (US$ Million) Table 92. Asia BNCT Treatment Revenue by Application (2027-2032) & (US$ Million) Table 93. Asia BNCT Treatment Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 94. Asia BNCT Treatment Revenue by Region (US$ Million) & (2021-2026) Table 95. Asia BNCT Treatment Revenue by Region (US$ Million) & (2027-2032) Table 96. SAMEA BNCT Treatment Revenue by Type (2021-2026) & (US$ Million) Table 97. SAMEA BNCT Treatment Revenue by Type (2027-2032) & (US$ Million) Table 98. SAMEA BNCT Treatment Revenue by Application (2021-2026) & (US$ Million) Table 99. SAMEA BNCT Treatment Revenue by Application (2027-2032) & (US$ Million) Table 100. SAMEA BNCT Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. SAMEA BNCT Treatment Revenue by Country (2021-2026) & (US$ Million) Table 102. SAMEA BNCT Treatment Revenue by Country (US$ Million) & (2027-2032) Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. BNCT Treatment Image Figure 2. Global BNCT Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global BNCT Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 4. Equipment Image Figure 5. Solution Image Figure 6. Drug Image Figure 7. Global BNCT Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global BNCT Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 9. Head and Neck Cancer Image Figure 10. Brain Tumor Image Figure 11. Others Image Figure 12. Global BNCT Treatment Market Size (US$ Million) & (2021-2032) Figure 13. Global BNCT Treatment Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global BNCT Treatment Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global BNCT Treatment Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global BNCT Treatment Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global BNCT Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global BNCT Treatment Revenue Market Share by Type (2021-2032) Figure 20. Global BNCT Treatment Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global BNCT Treatment Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global BNCT Treatment Revenue Market Share by Application (2021-2032) Figure 23. North America BNCT Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America BNCT Treatment Revenue Share by Type (2021-2032) Figure 25. North America BNCT Treatment Revenue Share by Application (2021-2032) Figure 26. North America BNCT Treatment Revenue Share by Country (2021-2032) Figure 27. United States BNCT Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada BNCT Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico BNCT Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe BNCT Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe BNCT Treatment Revenue Share by Type (2021-2032) Figure 32. Europe BNCT Treatment Revenue Share by Application (2021-2032) Figure 33. Europe BNCT Treatment Revenue Share by Country (2021-2032) Figure 34. Germany BNCT Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France BNCT Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. BNCT Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy BNCT Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain BNCT Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia BNCT Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands BNCT Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries BNCT Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China BNCT Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China BNCT Treatment Revenue Share by Type (2021-2032) Figure 44. China BNCT Treatment Revenue Share by Application (2021-2032) Figure 45. Asia BNCT Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia BNCT Treatment Revenue Share by Type (2021-2032) Figure 47. Asia BNCT Treatment Revenue Share by Application (2021-2032) Figure 48. Asia BNCT Treatment Revenue Share by Region (2021-2032) Figure 49. Japan BNCT Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea BNCT Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India BNCT Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia BNCT Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan BNCT Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia BNCT Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA BNCT Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA BNCT Treatment Revenue Share by Type (2021-2032) Figure 57. SAMEA BNCT Treatment Revenue Share by Application (2021-2032) Figure 58. SAMEA BNCT Treatment Revenue Share by Country (2021-2032) Figure 59. Brazil BNCT Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina BNCT Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile BNCT Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia BNCT Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru BNCT Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia BNCT Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel BNCT Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE BNCT Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey BNCT Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran BNCT Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt BNCT Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Equipment
  • Solution
  • Drug
Applications
  • Head and Neck Cancer
  • Brain Tumor
  • Others
Companies covered
  • Neutron Therapeutics
  • Sumitomo Heavy Industries
  • International Particle Therapy Inc (IPT)
  • RaySearch
  • Neuboron Medtech
  • TAE Life Sciences
  • Stella Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 BNCT Treatment Market by Type
  3. 1.2.1 Global BNCT Treatment Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Equipment
  5. 1.2.3 Solution
  6. 1.2.4 Drug
  7. 1.3 BNCT Treatment Market by Application
  8. 1.3.1 Global BNCT Treatment Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Head and Neck Cancer
  10. 1.3.3 Brain Tumor
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 BNCT Treatment Market Dynamics
  1. 2.1 BNCT Treatment Industry Trends
  2. 2.2 BNCT Treatment Industry Drivers
  3. 2.3 BNCT Treatment Industry Opportunities and Challenges
  4. 2.4 BNCT Treatment Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global BNCT Treatment Market Perspective (2021-2032)
  2. 3.2 Global BNCT Treatment Growth Trends by Region
  3. 3.2.1 Global BNCT Treatment Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global BNCT Treatment Market Size by Region (2021-2026)
  5. 3.2.3 Global BNCT Treatment Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global BNCT Treatment Revenue by Players
  2. 4.1.1 Global BNCT Treatment Revenue by Players (2021-2026)
  3. 4.1.2 Global BNCT Treatment Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global BNCT Treatment Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global BNCT Treatment Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global BNCT Treatment Key Players Headquarters & Area Served
  7. 4.4 Global BNCT Treatment Players, Product Type & Application
  8. 4.5 Global BNCT Treatment Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global BNCT Treatment Market CR5 and HHI
  11. 4.6.3 2025 BNCT Treatment Tier 1, Tier 2, and Tier 3
5 BNCT Treatment Market Size by Type
  1. 5.1 Global BNCT Treatment Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global BNCT Treatment Revenue by Type (2021-2032)
  3. 5.3 Global BNCT Treatment Revenue Market Share by Type (2021-2032)
6 BNCT Treatment Market Size by Application
  1. 6.1 Global BNCT Treatment Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global BNCT Treatment Revenue by Application (2021-2032)
  3. 6.3 Global BNCT Treatment Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Neutron Therapeutics
  2. 7.1.1 Neutron Therapeutics Company Information
  3. 7.1.2 Neutron Therapeutics Business Overview
  4. 7.1.3 Neutron Therapeutics BNCT Treatment Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Neutron Therapeutics BNCT Treatment Product Portfolio
  6. 7.1.5 Neutron Therapeutics Recent Developments
  7. 7.2 Sumitomo Heavy Industries
  8. 7.2.1 Sumitomo Heavy Industries Company Information
  9. 7.2.2 Sumitomo Heavy Industries Business Overview
  10. 7.2.3 Sumitomo Heavy Industries BNCT Treatment Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Sumitomo Heavy Industries BNCT Treatment Product Portfolio
  12. 7.2.5 Sumitomo Heavy Industries Recent Developments
  13. 7.3 International Particle Therapy Inc (IPT)
  14. 7.3.1 International Particle Therapy Inc (IPT) Company Information
  15. 7.3.2 International Particle Therapy Inc (IPT) Business Overview
  16. 7.3.3 International Particle Therapy Inc (IPT) BNCT Treatment Revenue and Gross Margin (2021-2026)
  17. 7.3.4 International Particle Therapy Inc (IPT) BNCT Treatment Product Portfolio
  18. 7.3.5 International Particle Therapy Inc (IPT) Recent Developments
  19. 7.4 RaySearch
  20. 7.4.1 RaySearch Company Information
  21. 7.4.2 RaySearch Business Overview
  22. 7.4.3 RaySearch BNCT Treatment Revenue and Gross Margin (2021-2026)
  23. 7.4.4 RaySearch BNCT Treatment Product Portfolio
  24. 7.4.5 RaySearch Recent Developments
  25. 7.5 Neuboron Medtech
  26. 7.5.1 Neuboron Medtech Company Information
  27. 7.5.2 Neuboron Medtech Business Overview
  28. 7.5.3 Neuboron Medtech BNCT Treatment Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Neuboron Medtech BNCT Treatment Product Portfolio
  30. 7.5.5 Neuboron Medtech Recent Developments
  31. 7.6 TAE Life Sciences
  32. 7.6.1 TAE Life Sciences Company Information
  33. 7.6.2 TAE Life Sciences Business Overview
  34. 7.6.3 TAE Life Sciences BNCT Treatment Revenue and Gross Margin (2021-2026)
  35. 7.6.4 TAE Life Sciences BNCT Treatment Product Portfolio
  36. 7.6.5 TAE Life Sciences Recent Developments
  37. 7.7 Stella Pharma
  38. 7.7.1 Stella Pharma Company Information
  39. 7.7.2 Stella Pharma Business Overview
  40. 7.7.3 Stella Pharma BNCT Treatment Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Stella Pharma BNCT Treatment Product Portfolio
  42. 7.7.5 Stella Pharma Recent Developments
8 North America
  1. 8.1 North America BNCT Treatment Revenue (2021-2032)
  2. 8.2 North America BNCT Treatment Revenue by Type (2021-2032)
  3. 8.2.1 North America BNCT Treatment Revenue by Type (2021-2026)
  4. 8.2.2 North America BNCT Treatment Revenue by Type (2027-2032)
  5. 8.3 North America BNCT Treatment Revenue Share by Type (2021-2032)
  6. 8.4 North America BNCT Treatment Revenue by Application (2021-2032)
  7. 8.4.1 North America BNCT Treatment Revenue by Application (2021-2026)
  8. 8.4.2 North America BNCT Treatment Revenue by Application (2027-2032)
  9. 8.5 North America BNCT Treatment Revenue Share by Application (2021-2032)
  10. 8.6 North America BNCT Treatment Revenue by Country
  11. 8.6.1 North America BNCT Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America BNCT Treatment Revenue by Country (2021-2026)
  13. 8.6.3 North America BNCT Treatment Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe BNCT Treatment Revenue (2021-2032)
  2. 9.2 Europe BNCT Treatment Revenue by Type (2021-2032)
  3. 9.2.1 Europe BNCT Treatment Revenue by Type (2021-2026)
  4. 9.2.2 Europe BNCT Treatment Revenue by Type (2027-2032)
  5. 9.3 Europe BNCT Treatment Revenue Share by Type (2021-2032)
  6. 9.4 Europe BNCT Treatment Revenue by Application (2021-2032)
  7. 9.4.1 Europe BNCT Treatment Revenue by Application (2021-2026)
  8. 9.4.2 Europe BNCT Treatment Revenue by Application (2027-2032)
  9. 9.5 Europe BNCT Treatment Revenue Share by Application (2021-2032)
  10. 9.6 Europe BNCT Treatment Revenue by Country
  11. 9.6.1 Europe BNCT Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe BNCT Treatment Revenue by Country (2021-2026)
  13. 9.6.3 Europe BNCT Treatment Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China BNCT Treatment Revenue (2021-2032)
  2. 10.2 China BNCT Treatment Revenue by Type (2021-2032)
  3. 10.2.1 China BNCT Treatment Revenue by Type (2021-2026)
  4. 10.2.2 China BNCT Treatment Revenue by Type (2027-2032)
  5. 10.3 China BNCT Treatment Revenue Share by Type (2021-2032)
  6. 10.4 China BNCT Treatment Revenue by Application (2021-2032)
  7. 10.4.1 China BNCT Treatment Revenue by Application (2021-2026)
  8. 10.4.2 China BNCT Treatment Revenue by Application (2027-2032)
  9. 10.5 China BNCT Treatment Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia BNCT Treatment Revenue (2021-2032)
  2. 11.2 Asia BNCT Treatment Revenue by Type (2021-2032)
  3. 11.2.1 Asia BNCT Treatment Revenue by Type (2021-2026)
  4. 11.2.2 Asia BNCT Treatment Revenue by Type (2027-2032)
  5. 11.3 Asia BNCT Treatment Revenue Share by Type (2021-2032)
  6. 11.4 Asia BNCT Treatment Revenue by Application (2021-2032)
  7. 11.4.1 Asia BNCT Treatment Revenue by Application (2021-2026)
  8. 11.4.2 Asia BNCT Treatment Revenue by Application (2027-2032)
  9. 11.5 Asia BNCT Treatment Revenue Share by Application (2021-2032)
  10. 11.6 Asia BNCT Treatment Revenue by Country
  11. 11.6.1 Asia BNCT Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia BNCT Treatment Revenue by Country (2021-2026)
  13. 11.6.3 Asia BNCT Treatment Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA BNCT Treatment Revenue (2021-2032)
  2. 12.2 SAMEA BNCT Treatment Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA BNCT Treatment Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA BNCT Treatment Revenue by Type (2027-2032)
  5. 12.3 SAMEA BNCT Treatment Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA BNCT Treatment Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA BNCT Treatment Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA BNCT Treatment Revenue by Application (2027-2032)
  9. 12.5 SAMEA BNCT Treatment Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA BNCT Treatment Revenue by Country
  11. 12.6.1 SAMEA BNCT Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA BNCT Treatment Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA BNCT Treatment Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst